Anne M. Landau, PhD, has investigated preclinical models of Parkinson’s disease (PD) for the past 20 years. In 2007, she received a PhD from the department of physiology at McGill University in Montreal, Canada, where her project focused on neuroprotection in PD. She then conducted postdoctoral fellowships at the University of British Columbia, Vancouver, Canada, and Aarhus University, Aarhus, Denmark, where she trained in positron emission tomography (PET). In 2015, Dr. Landau became an associate professor at the Translational Neuropsychiatry Unit and the department of nuclear medicine and PET Center at Aarhus University. She leads a group that uses PET to study the biochemical changes in relevant rodent and minipig models of neuropsychiatric and neurodegenerative disorders. Ongoing projects are related to testing PD-relevant therapies, including human embryonic stem cells and deep brain stimulation in minipig PD models, and applying novel imaging markers to PD models.